文献速递临床生化临床血液与体液

持续葡萄糖监测在症状前1型糖尿病中的作用日益增加:优势、局限及与实验室检测的比较

Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing.
PubMed 文献 · Clin Chem Lab Med · 2023-06-23

本文综述了口服葡萄糖耐量试验、糖化血红蛋白、果糖胺和糖化白蛋白在症状前1型糖尿病分期中的应用,并通过案例展示了持续葡萄糖监测(CGM)的临床经验,主张CGM在监测高危儿童代谢恶化和疾病进展中应发挥更大作用。

要点

  • CGM可检测症状前、胰岛自身抗体阳性高危个体的早期血糖异常。
  • 早期识别可降低糖尿病酮症酸中毒(DKA)风险并确定预防试验资格。
  • CGM在监测代谢恶化和疾病进展方面应发挥更大作用。

核心结论

  • CGM在症状前1型糖尿病监测中作用日益增加,可检测早期血糖异常并监测代谢恶化。

研究设计与样本

  • 综述性文章,结合 illustrative cases 描述临床经验。

主要发现

  • 症状前1型糖尿病存在早于典型症状的血糖稳态异常。
  • CGM可检测早期血糖异常并监测代谢恶化。
  • 早期识别可降低DKA风险并确定预防试验资格。

关键数值与推荐

  • 口服葡萄糖耐量试验(OGTT)和糖化血红蛋白(HbA1c)用于T1D分期和评估进展风险。
  • 果糖胺和糖化白蛋白可用于症状前T1D评估。

临床怎么用

  • 对胰岛自身抗体阳性的高危儿童,可使用CGM监测代谢恶化和疾病进展。
  • 早期识别症状前T1D有助于降低DKA风险并评估预防试验资格。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Type 1 diabetes (T1D) is well-recognised as a continuum heralded by the development of islet autoantibodies, progression to islet autoimmunity causing beta cell destruction, culminating in insulin deficiency and clinical disease. Abnormalities of glucose homeostasis are known to exist well before the onset of typical symptoms. Laboratory-based tests such as the oral glucose tolerance test (OGTT) and glycated haemoglobin (HbA1c) have been used to stage T1D and assess the risk of progression to clinical T1D. Continuous glucose monitoring (CGM) can detect early glycaemic abnormalities and can therefore be used to monitor for metabolic deterioration in pre-symptomatic, islet autoantibody positive, at-risk individuals. Early identification of these children can not only reduce the risk of presentation with diabetic ketoacidosis (DKA), but also determine eligibility for prevention trials, which aim to prevent or delay progression to clinical T1D. Here, we describe the current state with regard to the use of the OGTT, HbA1c, fructosamine and glycated albumin in pre-symptomatic T1D. Using illustrative cases, we present our clinical experience with the use of CGM, and advocate for an increased role of this diabetes technology, for monitoring metabolic deterioration and disease progression in children with pre-symptomatic T1D.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Joshi K, Harris M, Cotterill A, et al. Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing. Clin Chem Lab Med. 2023. PMID: 37349976. doi:10.1515/cclm-2023-0234

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。